Enanta Pharma Earnings Preview
Portfolio Pulse from Benzinga Insights
Enanta Pharma (NASDAQ:ENTA) is scheduled to release its quarterly earnings report on Monday, 2023-11-20, with an estimated EPS of $-2.00. Investors are looking for a beat on this estimate and positive guidance for future growth. Historically, Enanta has experienced share price drops following earnings reports, even when beating EPS estimates. Over the past year, ENTA shares have declined by 81.27%, indicating potential concern among long-term shareholders ahead of the earnings release.
November 17, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Enanta Pharma is expected to report an EPS of $-2.00 for the upcoming earnings, with investors focusing on potential positive guidance. Historical data shows share price declines following earnings reports, despite beating estimates.
Given the historical trend of share price declines after earnings reports, even when Enanta Pharma beats EPS estimates, there is a likelihood of a negative short-term impact on ENTA's stock price. The significant 81.27% decline over the past year further suggests investor concern, which may exacerbate negative reactions to any less-than-favorable earnings details.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100